Cytoxan (Cyclophosphamide) for Myeloma

The Cytoxan brand name has been discontinued in the U.S. Generic alternatives may be available.

Overview

Cytoxan is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating cancers including multiple myeloma and many types of leukemia and lymphoma. In cases of myeloma, Cytoxan is often combined with other drugs such as Velcade or Thalomid and a corticosteroid. Cytoxan is also known by its drug name, cyclophosphamide. Cytoxan is an anti-cancer drug used in chemotherapy. Cytoxan is a member of a class of drugs called alkylating agents. Cytoxan is believed to work by preventing the production of DNA in cells, thereby blocking cell division.

How do I take it?

Cytoxan can be administered as an intravenous infusion, taken orally, or injected into the muscle.

Side effects

Common side effects of Cytoxan include nausea, vomiting, temporary hair loss, darkening of the skin and nails, loss of appetite, fatigue, increased risk for infection, and anemia. Rare but serious side effects of Cytoxan include the risk of increased risk of infection, increased risk for some types of cancer, liver disease, and heart and lung toxicity.

For more details about this treatment, visit:

Cytoxan — Chemocare

Drug Therapy for Multiple Myeloma — American Cancer Society